NAV12/5/2016 Chg.-0.0300 Type of yield Investment Focus Investment company
504.1900EUR -0.01% reinvestment Equity Worldwide Bellevue Asset Mgmt. 

Monthly performance

  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
2009 - - - - -2.45 6.30 6.58 -0.94 3.24 -11.67 4.98 5.10 -
2010 4.70 4.84 5.87 0.14 -4.99 -3.21 -3.09 0.49 4.34 4.57 1.80 4.34 +20.78%
2011 -4.93 -0.52 -1.71 3.48 3.28 -1.57 -1.16 -13.41 -0.17 1.99 4.08 6.82 -5.27%
2012 12.52 -0.44 3.83 1.03 6.49 1.14 7.03 -0.33 3.59 -9.18 4.64 -1.86 +30.44%
2013 4.47 5.61 9.77 6.55 4.77 -4.15 12.35 -2.03 6.33 -3.56 8.10 -0.15 +57.85%
2014 12.43 4.14 -10.65 -4.57 4.54 8.21 1.21 13.15 3.08 11.08 3.16 2.38 +56.40%
2015 15.76 6.41 5.03 -7.83 12.31 -1.95 2.94 -12.77 -11.98 10.68 7.11 -1.84 +20.78%
2016 -22.77 -5.53 -0.31 3.53 6.38 -9.16 12.51 -2.37 2.05 -11.83 12.41 -1.86 -

Calculated values

  YTD 6 Months 1 Year 3 Years 5 Years
Volatility 33.08% 28.53% 32.93% 30.86% 26.92%
Sharpe ratio -0.66 -0.08 -0.50 0.49 1.01
Best month +12.51% +12.51% +12.51% +15.76% +15.76%
Worst month -22.77% -11.83% -22.77% -22.77% -22.77%
Maximum loss -33.27% -19.80% -33.88% -44.14% -44.14%
Outperformance -11.38% - -8.99% +5.92% +91.08%
 
All quotes in EUR

Tranches

Name   Type of yield Repurchase p. 1 Year 3 Years
BB Adamant Biotech I USD reinvestment 403.7400 -17.67% +19.26%
BB Adamant Biotech I EUR reinvestment 504.1900 -16.69% +51.86%
BB Adamant Biotech I CHF reinvestment 359.8000 -16.82% +34.25%
BB Adamant Biotech B USD reinvestment 381.3400 -18.29% +16.63%
BB Adamant Biotech B CHF reinvestment 338.0100 -17.43% +31.29%
BB Adamant Biotech B EUR reinvestment 474.4500 -17.31% +48.51%

Performance

YTD
  -20.66%
6 Months
  -1.35%
1 Year
  -16.69%
3 Years  
+51.86%
5 Years  
+229.23%
Since start  
+303.35%
Year
2015  
+20.78%
2014  
+56.40%
2013  
+57.85%
2012  
+30.44%
2011
  -5.27%
2010  
+20.78%